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This study is concerned with a syngeneic transplant-
able mammary adenocarcinoma 13762 in Fisher 344 adult female 
rats. The primary objective is to describe the biological 
behavior of this tumor-host system with special emphasis on 
the response of lymphoid tissues to tumor growth. Thereby, 
this study will serve as a basis for further studies on the 
host's response to various manipulations of this system such 
as surgery, immunotherapy and chemotherapy. 
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THE RESEARCH PROBLEM 
Introduction 
There is much research today on cancer. It is a very 
broad field. Studies range from basic research on deoxy-
ribonucleic acid (DNA) to clinical trials in human patients. 
The ultimate goal is to find ways to prevent and to cure 
cancer. An approach to a problem of this magnitude is to 
dissect it into its parts and to study each in detail. Ex-
periments are designed so that as many variables as possible 
are eliminated. Tumor-host model systems are valuable be-
cause they have a minimum of variables when compared with 
spontaneously occurring tumors in humans. This report con-
cerns a tumor-host model for breast cancer in women, the rat 
mammary adenocarcinoma 13762 in adult female Fisher 344 rats. 
It is a syngeneic tumor-host system. 
Statement of the Problem 
The problem is to define, on morphologic bases, by 1 ight 
microscopy, the syngeneic mammary adenocarcinoma 13762 as a 
tumor-host system. The definition must include a detailed 
description of the tumor in its primary and metastatic sites; 
also, the mode of spread in the body, location of metastases, 
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and the response of the lymphoid organs such as spleen, 
lymph nodes and thymus to tumor growth and metastases. 
Purpose of the Study 
The purpose of this study is to characterize the rat 
mammary adenocarcinoma 13762 in Fisher 344 rats in the ab-
sence of any manipulation, so that this system may be used 
in future studies with confidence that the biological be-
havior is predictable and well described. Then, manipula-
tions, such as would be feasible in women with breast can-
cer, could be applied to this rat-tumor system and one 
could be confident that changes seen in the host are re-
lated to interference with the tumor-host relationship. 
Literature Review 
The rat mammary adenocarcinoma 13762 in Fisher adult fe-
male rats was originally described by Segaloff in 1966 (1). 
He induced the tumor with 7, 12-dimethylbenzanthracene (DMBA). 
Transplantation was always successful and all treated rats 
died from the tumor. In 1974 Bogden~~ (2) reported stud-
ies they had done that included the effects of surgery, chemo-
therapy and immunotherapy on metastases of this tumor. These 
treatments were used alone and in combination. In the un-
treated group the rats developed large tumors and lived 
+ 47.8- 6.9 days. When the only treatment was excision of 
the primary tumor on day 18 after implantation the rats 
1 ived 65.5! 8 days. 
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Chemotherapy alone with the 178-estradiol diester of 
p~[N, N-bis (2-chloroethyl amino)] phenylacetic acid at 
5 mg/kg/day per os for 28 days produced oncolysis and cured ----
25% of the rats of their tumors. In the remaining animals 
there was regrowth of the tumor, despite continued chemo-
therapy. These animals lived 87.3 ± 10.5 days. 
When 10 days of chemotherapy was given either before 
o r aft e r s u r g i c a 1 r e mo v a 1 of the t u mo r , 7 5 • 5% of the rats 
were cured of their tumors, but if chemotherapy was given 
for 28 days either before or after surgery the cure rate 
was reduced to 61%. This effect was attributed to the im-
munosuppressive action of the drug. 
When surgery was followed by one intraperitoneal in-
jection of 10 mg of MSF-MB (Methanol Soluble Fraction-
Mycobacterium butyricum) as a nonspecific immunological ad-
juvant 10-20% of the rats were cured of their tumors. Nine-
ty to 100% of the rats were cured when treatment included 
10 days of chemotherapy before or after surgery and MSF-MB. 
Much more has been done recently to study the immune re-
sponse to the 13762 rat mammary adenocarcinoma in syngeneic 
rats in hopes of better understanding the pathogenesis of the 
tumor growth and metastasis. Most of these effects have been 
directed toward in vitro tests of cell mediated immunity. 
Fortner et al (3) described a microcytotoxicity assay tech-
nique that they used to measure cell mediated cytotoxicity 
(CMC). Their results showed that CMC appeared 4 days after 
tumor implantation, reached a maximum 2-4 days later, then 
suddenly disappeared with continued tumor growth. 
Kuperman et al (4) showed that the cytolytic effector 
cells induced by tumor 13762 are specific killers of that 
t u mo r c e 1 1 1 i n e on 1 y. In another report Kuperman et al (5) 
described the existence of suppressor cells and memory 
cells in spleens from animals bearing the 13762 rat mammary 
adenocarcinoma and showed that they had a modulatory effect 
on the expression of cellular cytotoxicity. 
More recently Kreider~ al (6) studied the 13762 tumor 
for potential use as a model for BCG (Bacillus Calmette-
Guerin) immunotherapy. They found that there was greater 
suppression of the tumor when the cells were transplanted 
mixed in the BCG. 
Only brief morphologic descriptions of the tumor have 
been published (2, 6). There are no descriptions in the 
literature to my knowledge of the cellular changes that oc-
cur in the lymphoid tissues of rats during the growth of the 
13762 mammary adenocarcinoma even though extensive studies 
have been done on individual lymphoid cells. 
Sass et al (7) reported on the incidence of spontaneous 
neoplasms in Fisher 344 Rats during their natural life span. 
Of all tumors seen, the mammary tumors had an incidence of 
40.6% in females and 23.1% in males. Sixty two of the 78 
mammary tumors in females and 34 of 37 of the mammary tumors 
in males were fibroadenomas. The rest were adenocarcinomas 
and adenoacanthomas. No metastases were seen from any of 
the mammary tumors. 
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CHAPTER II 
METHODS AND PROCEDURES 
Introduction 
This is basically a histopathological study of the 13762 
rat mammary adenocarcinoma and of the lymphoid tissues in the 
rats with this tumor. 
Population 
One hundred and twenty-four adult (6-week-old) Fisher 
344 female rats were usedo They were obtained from Charles 
Rivers Laboratories in Wilmington, Massachusetts. They were 
kept in temperature (21°C) and ventilation-controlled rooms 
and given "Purina Lab Chow" (Purina Co., St. Louis, Missouri) 
and water ad libitum. Lights were on for 12 hours and off 
for 12 hours. 
Tumor Strain 
The rat mammary adenocarcinoma 13762, which is syngeneic 
in Fisher 344 rats, was used in this study. The tumor was 
obtained from the Mason Research Institute Tumor Bank in 
Worchester, Massachusetts, through the courtesy of Arthur E. 
Bogden. This was originally a DMBA-induced tumoro It has 
a lag phase of 6-8 days before tumor growth is measurableo 
The average survival time of a rat with the tumor is 42.1 :! 
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6.9 days. At the time of death there are metastases in the 
lungs and sometimes in the abdominal organs. 
Instrumentation and Techniques 
A young tumor (7-14 days old) was used for transplanta-
tion. It was excised from a rat killed by a lethal dose of 
chloroform. The tumor was trimmed free of surrounding con-
nective tissue and then put in a manual slicer that allowed 
0.5 mm-thick slices to be cut. The slices were transferred 
to small dishes with 1-mm squares etched on the bottom. 
Pieces of nonnecrotic tumor, 1 mm square, were used for 
transplantation. The tissue was held in Hepes solution un-
til the time of transplant which was within a few minutes 
of sectioning. 
The skin was shaved over the dorsa-caudal part of the 
left flank. The rats were anesthetized with ether and a 
1-2 mm incision was made in the skin just in front of the 
hind leg. A 16-gauge trochar was used to place the 1 mm 
square of tissue approximately 1 em anterior to the skin in-
cision. No sutures were used in the skin. 
The tumors were measured with a Vernier caliper by three 
different persons and the average value of the three was used 
for the chart on the growth rate. The formula used to calcu-
dl d2 d3) late the volumes is V = 4/3~ <-r x -r x -z. 
Tissues from the rats were fixed for light microscopic 
examination in 10% buffered formalin. Tissues were dehydrat-
ed and embedded in paraffin and sectioned at 6~m. The rou-
tine stain used was hematoxylin and eosin. Special stains 
included Pollack's trichrome and periodic acid-Schiff (PAS}. 
Design of Experiment 
Thirty-five rats were used to establish the rate of 
growth of the tumor and five were killed at successive 1-
week intervals beginning at 20 days after receiving the 
tumor. 
The remaining 89 rats were from unmanipulated tumor 
control groups from other experiments not discussed here; 
for example, the experiment on the effect of surgical re-
moval of the mass on survival time. Some of these tumors 
were measured and are included in the growth table. Some 
rats were killed early in the growth of the tumor to try 
to correlate changes in the lymphoid tissues with the re-
ported appearance and disappearance of cell-mediated cyto-
toxicity. 
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The temporal distribution of rats examined histological-
ly after implantation was as follows: 14 rats during the 
1st week, 11 during the 2nd, 15 in the 3rd, 23 in the 4th, 
28 in the 5th, 10 in the 6th, 9 in the 7th, 8 in the 8th week 
and 6 between the 8th and 11th week. 
CHAPTER II I 
ANALYSIS OF THE DATA 
Introduction 
The following is a record of the growth rate and a des-
cription of the morphology at the light microscopic level of 
the tumor growth, metastases and of the concomitant changes 
in the lymph nodes, spleen and thymus. The tumor-host sys-
tem must be as well defined as possible before attempts are 
made to alter the system so that when a change is seen, one 
knows whether or not it has been caused by the manipulation. 
Growth Rate Measurements 
It is 6 to 7 days post implantation (PI) before a meas-
surable nodule is detectedo By 1~ days the mass triples and 
is about 50 mm 3 and by 28 days the volume reaches approxi-
mately ~900 mm 3 , an increase of almost 100 fold from the six-
day-old tumor. At 35 days, the tumor volume is about 15,000 
mm 3 after which time many of the tumors become ulcerated and 
rupture through the epidermis allowing the liquified necrotic 
tissue to drain from the area. This changes the dimensions 
of the tumor, therefore, measurements beyond this time are 
not recorded (see chart on following page). Lung metastases 
are not seen grossly until 35 days after implantation at 
8 
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which time almost all animals have discrete masses in the 
lungs. At 28 days gross tumor is recognized in the regional 
lymph node in about 50% of the animals and by 35 days all 
have tumor in the inguinal node draining the primary tumor 
site. At 42 days a small number of rats have enlarged 
spleens and beginning atrophy of the thymus. By 49 days 
virtually all animals have spleens 1.5-2 times normal size 
and severe thymic atrophy. 
TABLE I 
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The chart is a record of tumor volume growth in mm 3 x10 3 
in days after implantation. Note that the tumor is not big 
enough to measure with a Vernier caliper until about one 
week after implantation, then there is a logarithmic increase 
in mass with time for about 2 weeks. By 5 weeks after im-
plantation the tumors are ulcerated so no further measure-
ments are .recorded. 
Histopathology of the Tumor 
The tumor is an adenocarcinoma. The cells are large, 
pleomorphic and arranged in acini or in sheets. There is a 
wide range in size and shape of the nuclei. Nucleoli are 
occasionally seen. The chromatin pattern is light and usual-
ly diffuse although there is some clumping of chromatin at 
the nuclear rim. The cytoplasm is slightly basophilic and 
frequently has a foamy appearance or contains large single 
or multiple clear vacuoles (Fig. 1). The cytoplasm is light-
ly periodic acid-Schiff (PAS) positive. With the trichrome 
stain the cytoplasm is grey green and the nucleus is red-
brown. 
There is histologic evidence that the tumor cell is a 
secreting one because proteinic droplets can be seen at the 
apices of young cells arranged in acini (Fig. 2) and the 
cytoplasm ls vacuolated in these viable cells. It is not 
vacuolation associated with degeneration and dying since 
there are no degenerative nuclear changes seen. 
Figure 1. Note the variation in nuclear size, 
diffuse and clumped distribution of chroma-
tin, occasional nucleolus (arrow) and the 
foamy cytoplasm. H&E (x1200) 
Figure 2. A tumor acinus with secretory 
globules (arrow) at apices of cells. 
H&E (x48o) 
J J 
Most commonly the tumor forms acini but occasionally 
forms sheets as in figure 3. 
Figure 3. 
sheets. 
The tumor cells are mainly in 
H&E (x75) 
Also characteristic of this tumor are the early appear-
ance of necrosis while the tumor is sti 11 small {<1cm 3 ) and 
the high mitotic index (Figure 4). 
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As the tumor grows it becomes infarcted in the more cen-
tral areas (Figure 5), presumably because it has outgrown its 
blood supply. Also it has poorly formed lymphatics that al-
low for increased hydrostatic pressure within the tumor which 
predisposes to pressure necrosis. 
Figure 4. Mitotic figures (m) and areas of 
necrosis (arrows). H&E (x480) 
Figure 5. This tumor is 14 days old. 
Necrotic vessel (arrow) surrounded 




Initially the young tumor does not invade the panniculus 
muscle of the skin but tends to spread laterally in the con-
nective tissue of the subcutis (Figure 6). 
Figure 6. This is a 3-day-old tumor in the 
subcutaneous tissue. Note the elliptical 
shape and tendency to grow beneath the 
panniculus muscle rather than through it. 
H&E (x75) 
Eventually the tumor grows outward through the subcu-
taneous muscle (Figure 7) and through the dermis and epi-
dermis. It causes necros is of the skin and ulceration which 
frequently l e aves a gaping hole after necroti c contents have 
been discharged. 
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Figure 7. The 12-day-old tumor has begun to 
invade between the bundles of subcutaneous 
muscle. H&E (x75) 
As the tumor grows, there are increased numbers of blood 
vessels and lymphatic vessels in the connective tissue sur-
rounding the tumor. T h e t u mo r g rows by 1 o c a 1 i n f i 1 t r a t i on 
and expansion . Strings of tumor cells are seen growing a-
long lymphatic channels (Figure 8). 
Histopathology of t he Lymph Nodes 
Changes in the lymph nodes are predictable. The normal 
lymph node contains cortical follicles comprised mainly of 
small lymphocytes (Figure 9). There are very few germinal 
centers in the follicles. 
The normal medullary portion of the lymph node contains 
stroma l reticulum cells, macrophages and a few plasma cells. 
Figure 8. This is subcutaneous connective 
tissue next to the tumor. ~ote tumor 
growing along the wall of a lymphatic 
vessel (arrows). H&E (x480) 
Figure 9. Section of a normal lymph node 
through inactive cortical follicles com-




Concomitant with tumor growth there is progressive gen-
era] ized lymphadenopathy. This is characterized by increas-
ed numbers of germinal centers in follicles (Figure 10) and 
later diffuse plasmacytosis of the medulla (Figure 11). 
Cortical hyperplasia was seen initially in the regional node 
as early as 7 days after implantation of the tumor, and with-
in 20 days after implantation it was seen in the other lymph 
nodes, both peripheral and visceral. 
-.-~---~ 
Figure 10. Notice the germinal centers in 
the cortical follicles of the lymph node. 
H&E (x192) 
Metastases are first seen in the subcapsular sinus of 
the lymph node usually by 4 weeks after implantation. The 
tumor cells are in small clusters that contain mitotic fig-
ures and single necrotic cells (Figure 12). 
Figure 11. This is a section through the 
medulla of lymph node with diffuse 
plasmacytosis. H&E (x192) 
Figure 12. This is a metatasis in the sub-
capsular sinus of the regional lymph node 
Note the mitotic figure (arrow) and the 




The tumor grows along the subcapsular sinus and then be-
gins to extend into the cortex along the sinus between the 
follicles (Figure 13). Eventually tumor growth replaces the 
lymph node. 
.. 
. ... .~ 
' " 
Figure 13. This is a metastasis in there-
gional lymph node that is growing into 
the cortex along the sinus between the 
f o 1 1 i c 1 e s (a r row) • H & E ( x 7 5) 
The tumor has the same morphologic characteristics in 
the metastati c sites as it has in the primary implant. In 
both the lymph node and the lung the tumor forms in sheets 
and in acini and becomes necrotic. 
Young metastases in the lung take the form of small 
clusters of cells or appear to line alveoli. The tumor eel ls 
are easily distinguished from alveolar cells by their larger 
20 
s i z e , 1 a r g e r n u c 1 e i a n d mo r e b a s o p h i 1 i c c y t o p 1 a s m ( F i g u r e 
14). The lung metastases were seen by 5 weeks after implant-
ation and were most obvious initially in subpleural sites. 
The number of lung metastases tended to incr ease 1 inearly 
with time. 
Figure 14. In the lung the metastasis 
appears to line an alveolus. Note 
that the tumor cells are larger and 
d a r k e r (a r rows ) than the ad j ace n t 
cells. H&E (x480) 
Histopathology of the Spleen 
The splenic response to tumor growth follows a predict-
able pattern. The normal spleen in adult female Fisher 344 
rats is approximately 1.5 em long, 6 mm broad across the sur-
face opposite the mesenteric attachment, and 3 mm at its 
2 1 
thickest point which is through the mesenteric attachment. 
On transverse section, it is triangular. As the tumor grows 
the spleen gradually increases in size, very slowly at first, 
then more rapidly until it reaches 3-4 times normal size in 
rats dying of the tumor. The normal spleen has a fibromus-
cular capsule and light muscular trabeculae. The rest of 
the spleen is composed of 1/2-2/3 white pulp or periarterial 
lymphatic sheaths and 1/2-1/3 is red pulp. The sheaths are 
oriented around an artery and are composed of several layers 
of small lymphocytes (Figure 15). 
Figure 15. Normal spleen. Note the central 
artery (arrow) and the periarterial lymph-
atic sheath composed of small lymphocytes. 
H&E (x190) 
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Just peripheral to the central core there is a denser 
band of reticulum cells and macrophages (Figure 16). The 
red pulp contains red blood cells, a loose network of vas-
cular channels, hemosiderin-laden macrophages, Reticulum 
cells and a few red blood cell precursors. Lightly scatter-
ed through the red pulp are small lymphocytes singly and in 
small clusters (Figure 17). Also there are occasional mega-
ka ryocytes. 
By 12 days after implantation the spleen is slightly 
plumper than the normal spleen. This increase in size is 
mainly due to increased mass of the red pulp. The lymphatic 
sheaths are basically the same as normal except there are a 
few large lymphocytes centrally as in the beginning of the 
formation of germinal centers (Figure 18). 
Figure 16. Normal spleen. Note the general 
organization into lymphatic sheaths 
(arrow), concentric bands of reticulum 





Red pulp of normal spleen. Note 
arrangement of macrophages (m), 
cells (r) and small lymphocytes 
H&E (x780) 
Figure 18. Spleen from a rat 12 days Pl. 
Note the beginning of germinal centers 




The outer reticulum cell zone of the sheath is slightly 
larger and less sharply demarcated from the red pulp than in 
the normal spleen. Neutrophils are noted in the red pulp 
blood and there are nonsegmented neutrophils in the stroma. 
From days 17-25 after implantation, there is no change 
in the lymphatic sheaths, and in the red pulp there is an in-
crease in the number of clusters of small lymphocytes. There 
is also an increase in the number of mature and immature 
neutrophi 1 ic leukocytes and a slight increase in the number 
of megakaryocytes. 
By 31 days after implantation of the tumor, the spleen 
is increased in mass so that instead of being a sharply tri-
angular in cross section, it is more ellipsoid. It has a 
more uniform thickness from side to side. The red pulp is 
densely cellular and this accounts for the increase in size. 
The germinal centers in lymphatic sheaths are larger and more 
prominent. There is a concomitant decrease in small lympho-
cytes in the sheaths. In the red pulp there are 2 main cell 
types, lymphocytes and macrophages mixed in dense clusters . 
(Figures 19 and 20}. 
Several mitotic figures are seen in these clusters. 
There is no difference in the amount of hemato- or granulo-
poiesis compared with that of the last group. 
Gradually the lymphatic sheaths are replaced by reticu-
lum cells and the red pulp becomes a heterogeneous mass of 
clusters of small and large lymphocytes, macrophages, granulo-
poietic foci and megakaryocytes (Figure 20}. 
Figure 19. Spleen from a rat 31 days Pl. 
Note the dark clusters of lymphocytes 
and macrophages in the red pulp 
(arrows). H&E (x30) 
Compare this with the normal spleen 
i n F i g u re 1 6. 
Figure 20. Red pulp of spleen from a rat 55 
days Pl. The large multinucleate cell is 
a megakaryocyte. Band shape cells are im-
mature neutrophil leukocytes (b). Small 
dark cells without cytoplasm are red cell 
precursors (arrow), macrophages (m), small 
lymphocytes (sl) and large lymphocytes 
(1). H&E (x48o) 
25 
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Histopathology of the Thymus 
The only significant thymic changes occurred very late 
in the tumor growth. No recognizable changes occurred in 
the first 4 or 5 weeks. Only by the time the spleen had be-
come noticeably enlarged did the thymus begin to involute. 
No proliferative response of any kind was seen. 
The normal thymus has a broad outer band of small 
lymphocytes and a smaller medulla comprised of loose reticu-
lum cells, blood vessels, and macrophages (Figure 21). 
Figure 21. Normal thymus with dense outer 
zone of small lymphocytes and a loose, 
less cellular medul la. H&E (x?S) 
The thymus is very small and hard to recognize in the 
an i rna 1 d y i n g of the tumor. Frequently all that is seen 
27 
microscopically is stroma, an occasional Hassall's corpuscle 
and a few small lymphocytes (Figure 22). 
Figure 22. Atrophic thymus from a rat 55 
days PI. Note the stromal blood ves-
sels, Hassall's corpuscle (h) and a 
1 ight scattering of small lymphocytes 
(arrow). H&E (x190) 
Approximately 10% of the rats in this study had pulmon-
ary lesions consistent with mycoplasma pneumonia. No differ-
ences were noted in the peripheral lymph node or spleens be-
tween these animals and those that did not have pneumonia. 
CHAPTER IV 
DISCUSSION OF RESULTS 
Primary Tumor Growth 
In the growth rate table it is shown that the 13762 
tumor is a rapidly growing tumor; therefore it is especial-
ly suitable as an model because results of individual experi-
ments are obtained in a short time. Although it is not 
shown in the table the survival time was approximately the 
same as reported in Bodgen 1 s work (2). 
As Kreider reported (6}, when the tumors grow to 1-2 em 
in diameter there is central necrosis with the formation of 
fluid filled sacs. These would increase in size until they 
broke through the overlying skin and discharged their con-
tents. 
Tumor Metastases 
Lung metastases are not seen as early in this study as 
in Bodgen 1 s work (2). He reported that by day 18 after im-
plantation all of the animals had metastases to lungs or to 
other organs. The lungs were not serial-sectioned in this 
study and it is possible that the early small metastases were 
missed. Only rarely are tumor metastases seen in organs 
other than regional lymph nodes and lung and these are in 
28 
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the 1 iver of rats that 1 ived longer than the average. 
Lymph Nodes 
Tumor metastases are seen first in the cortical sinus 
of the inguinal lymph node that drains the tumor. Afferent 
lymphatics enter the lymph node through the cortical sinus. 
The proliferation of germinal centers seen in the rats is 
noted first in the regional lymph nodes by 7 days after i m-
plantation. The B cell response (germinal center hyper-
plasia} seems to be more related to humoral than to local 
events because germinal center hyperplasia is seen in all 
body lymph nodes, albeit a week or so later than in the re-
gional nodes. Tumor metastases are observed in the regional 
lymph nodes with extensive germinal center hyperplasia. The 
B cell response persists in all lymph nodes through the time 
that the rat dies of the tumoro 
Hunter et al ( 8) ' in their studies on invasive ductal 
carcinoma in the human mammary gland, found that sinus his-
tiocytosis in regional lymph nodes was correlated with a 
very good prognosis and that germinal center hyperplasia was 
correlated with a very poor prognosis. They hypothesized 
that the germinal centers may be producing blocking antibody 
which interferes with cell-mediated immunity. They also 
noted that in some animal models, including mammary tumors 
in mice, there was a clear correlation among tumor necrosis, 
germinal center hyperplasia and the onset of accelerated 
mammary tumor growth. This agrees with the findings reported 
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in this study. In none of the rats was sinus histiocytosis 
of the lymph nodes observed. 
In some recent work done on the 13762 rat mammary adeno-
carcinoma, Lucas (9) found that a blocking factor is produced 
and its major activity is in the lgG (Immunoglobulin G) frac-
tion of serum (unpublished data). This factor binds prefer-
entially to specific tumor immune lymphocytes and blocks 
lymphocyte cytotoxicity in vitro as well as enhancing tumor 
g row t h i n vi vo • 
The extreme plasmacytosis of the medulla of lymph nodes 
is seen after 3-4 weeks of tumor growth and persists through 
the time that the rat dies of the tumor. This is interpreted 
as indication of antibody production. This may be an effort 
to respond to the still circulating tumor antigen. If these 
are antitumor antibodies they may be ineffective against 
tumor cells that are coated already by a protective blocking 
antibody. Since necrosis is an early and consistent feature 
of this tumor, intracellular antigens may be released into 
the circulation, and antibodies to these substances may be 
ineffective in facilitating killing of intact cells. In any 
case, there is evidence of much antibody production in the 
face of rapidly growing tumor masses, so one must assume that 
antibodies are not doing anything related to tumor growth or 
are ineffective in suppressing tumor growth or that they en-
hance tumor growth. 
Fisher and Fisher (5) showed that the regional lymph 
node is very important in resistance to tumor growth in 
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studies with the syngeneic C3H mammary carcinoma in mice 
(10). With removal of the regional lymph node there is much 
less concomitant immunity, even when the animal had been pre-
viously immunized for as long as 28 days with a growing tumor. 
They compared this system with a chemically (methylcholanth-
rene) induced tumor in which the depressed resistance to 
tumor challenge was not observed when the regional lymph 
node was removed. They hypothesized that perhaps in the 
11 less antigenic 11 C3H mammary carcinoma system the regional 
lymph node was more important than in the 11 more antigenic 11 
chemically induced tumor host systems (11). 
Goldfarb and Hardy (12), in their work with the murine 
mammary adenocarcinoma in C3H/HeJ mice, measured the phyto-
hemaglutinin (PHA) responses of lymphocytes from regional 
and nonregional lymph nodes and from the spleen. They 
found that the regional node was the first lymphoid tissue 
to ~e maximally sensitized. The splenic response was later. 
These reports are brought into the discussion because there 
was evidence in my work that the regional lymph nodes re-
sponded before the nonregional lymph nodes and that perhaps 
the 13762 mammary adenocarcinoma is less antigenic than some 
others that are chemically induced. 
Bard et al (13) studied a methylcholanthrene-induced sar-
coma in mice and showed that although removal of the regional 
lymph node had no effect on the growth of the tumor or on re-
sistance to subsequent challenge, lymphoid cells from are-
gional lymph node from a tumor-hearing mouse would adoptively 
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transfer immunity to a previously unexposed mouse. This 
suggests that some factor(s) is interfering with the effect-
iveness of the lymph node response in mice with the rapidly 
grow i n g tumor. 
The Spleen 
It is well documented in several different animal tumor 
models that the spleen plays an important role in both pro-
tecting the body from tumor growth and enhancing tumor growth. 
In the methylcholanthrene induced mammary carcinomas in rats 
splenectomy increased the incidence of tumor and decreased 
the latency (14). In the DBA/2J mice with syngeneic mammary 
adenocarcinomas, there were no metastases without splenectomy 
(15). Nordlund and Gershon (16) in their work with the 
Cloudman (S91) melanoma in syngeneic DBA/2 mice, found that 
with large doses of tumor cells the spleen shortened the la-
tency whereas with low doses of tumor cells the spleen in-
creased the latency. 
Bard and Pilch (17) reported on successful adoptive 
transfer of immunity to tumor challenge using spleen cells 
from mice with a chemically induced sarcoma. 
The most significant change in the spleen in this study 
is the proliferation of lymphocytes and macrophages. Macro-
phages are well known for their phagocytic activity and per-
haps not so well known for their function as suppressor cells. 
Kirchner et al (18) reported in 1974 on the suppressor cell 
activity in spleens of mice with tumors induced by the Maloney 
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sarcoma virus. In these mice the spleens were enlarged and 
contained 3-4 times the normal number of mononuclear cells; 
phagocytic cells were increased to 3 times the normal number 
and there was a 5-10% decrease in T lymphocytes. The phyto-
hemagglutinin (PHA) response of spleen cells was decreased 
to 20% of the normal at 15 days after infection and at the 
same time there was the highest level of specific cytotoxic-
ity. The PHA response could be returned to almost normal by 
passing the spleen cells through an adherence column. When 
spleen cells from a mouse with the sarcoma were mixed with 
normal spleen cells there was a significant drop in the PHA 
response. These results indicate there is a good possibility 
in that model system that there are suppressor cells in the 
spleen and that the cells are the macrophages. 
Fortner et ~ (3) reported that in the 13762 rat mam-
mary adenocarcinoma the cytotoxicity reached a maximum 6-8 
days after implantation then abruptly disappeared. They 
identified the spleen as the source of the cytotoxic cells. 
They did not test the splenic cells for the PHA response. 
It is possible that the same type of cellular kinetics is 
occurring with the spleen cells from rats with the 13762 
mammary adenocarcinoma as in the mice infected with the 
Maloney sarcoma virus. 
Thymus 
The thymic atrophy was seen very late in the tumor 
growth. This could have been due to cachexia associated 
34 
with chronic illness of several kinds. It is seen in foals 
for example with bacterial infections that result in death. 
Perhaps it could be due to a humoral immunosuppressive factor 
elaborated by the tumor or elaborated by the lymphoid tissues. 
When the thymus became atrophied the spleen had consid-
erably increased in mass with large and small lymphocytes 
and macrophages. Possibly the immunosuppressive factor(s) 
that allow for tumor growth suppress the lymphoid cells in 
the thymus. 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
Summary 
It was found that the 13762 mammary adenocarcinoma is a 
rapidly growing tumor that metastasizes to the regional lymph 
nodes and lungs. The hyperplastic response in the lymph 
nodes and spleens was characteristic and predictable. The 
fact that the tumor grows rapidly in the face of this lymph-
oid response suggests that the response is ineffective in 
suppressing tumor growth. 
Conclusions 
The mammary adenocarcinoma 13762 in Fisher 344 adult 
female rats is a tumor host system that is stable and is one 
that gives a repeatable pattern of tumor growth and metas-
tases. That there is a characteristic immune response makes 
it a valuable model for future studies in immunotherapy 
and chemotherapy. 
Recommendations for Future Research 
This system is especially suited as a model for breast 
cancer in women. It is a mammary adenocarcinoma and it 
metastasizes to local lymph nodes and lungs as do many of 
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the breast cancers in women. Regional lymph nodes in rats 
with the tumor have germinal center hyperplasia, which In 
women is correlated with a poor prognosis. This system 
therefore would be ideally suited for studies in immuno-
therapy where efforts could be directed toward changing the 
responses in the regional lymph nodes. 
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